Intracerebroventricular infusion of angiotensin II in conscious sheep reduced renal sympathetic nerve activity to 38% of control at 1 nmol/h, and to 9-11% at higher doses, independent of baroreceptors.
Does intracerebroventricular angiotensin II alter renal sympathetic nerve activity in conscious sheep?
Intracerebroventricular angiotensin II has a direct central inhibitory action on renal sympathetic nerve activity mediated by AT-1 receptors, independent of baroreceptors.
The effect of central administration of angiotensin II (ANG II) on efferent renal sympathetic nerve activity (RSNA) was studied in conscious sheep. ANG II (1 nmol/h), infused for 30 min into the lateral cerebral ventricles in five sheep, did not alter mean arterial pressure (MAP) but reduced RSNA to 38 +/- 5% of control. Intracerebroventricular infusion of higher doses of ANG II (3 and 10 nmol/h), which increased MAP by 12 +/- 2 and 14 +/- 3 mmHg, respectively, reduced RSNA to 9 +/- 5 and 11 +/- 7% of control. MAP and RSNA gradually returned to control over a period of 2 h after the infusions. Intracerebroventricular losartan (1 mg/h for 1 h before, and then during, angiotensin infusion) blocked all the effects of angiotensin (3 nmol/h). Baroreflex relationships constructed from the beat-to-beat relationship of RSNA to diastolic pressure showed a significant leftward shift during intracerebroventricular ANG II compared with the control relationship. The beat-to-beat relationship between central venous pressure and RSNA was abolished during intracerebroventricular infusion of ANG II. These findings demonstrate that intracerebroventricular ANG II has a direct central inhibitory action on RSNA that is independent of both arterial and low-pressure baroreceptors. This effect of angiotensin is mediated by central angiotensin AT-1 receptors.
May et al. (Fri,) reported a other. Intracerebroventricular angiotensin II (ANG II) vs. Control was evaluated on Efferent renal sympathetic nerve activity (RSNA). Intracerebroventricular infusion of angiotensin II in conscious sheep reduced renal sympathetic nerve activity to 38% of control at 1 nmol/h, and to 9-11% at higher doses, independent of baroreceptors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: